CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

February 23, 2022 · earnings

ALLO earnings: a negative outcome, -5.7%

On February 23, 2022, Allogene Therapeutics, Inc. reached its earnings. The result was a negative outcome, and the stock moved -5.7% in the window around the event. It had already run -18.0% in the 30 days into the catalyst — the kind of pre-event run-up that often precedes binary readouts.

The move

$9.72
1d before
$9.17
Event day
$9.25
1d after
$9.15
5d after

Pre-catalyst setup

-18.0%
30-day run-up
6313%
30-day volatility
1.1×
volume spike